Related Experiment Video
Updated: Feb 14, 2026
Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells
Published on: May 2, 2017
Differential Expression of MiR-106b-5p and MiR-200c-3p in Newly Diagnosed Versus Chronic Primary Immune
Cheng Qian1,2, Wenying Yan1, Tengda Li3
1Center for Systems Biology, Soochow University, Suzhou, China.
Background/Aims:
MicroRNAs (miRNAs) have been described to have important roles in primary immune thrombocytopenia (ITP). To gain additional understanding, we have now further evaluated the involvement of miRNAs in ITP.
Methods:
Microarray experiments were performed to examine the expression profiles of miRNAs and mRNAs in samples from subjects with newly diagnosed ITP (G1), chronic ITP (G2), and normal controls. The systematic Pipeline of Outlier MicroRNA Analysis framework was applied to identify key miRNAs expressed in the G1 and G2 samples. Quantitative PCR and receiver operator characteristic curves were used to confirm the performance of key miRNAs.
Results:
Compared with normal controls, 14 miRNAs (12 over-expressed and 2 under-expressed) and 7 over-expressed miRNAs were identified as key in G1 and G2 samples, respectively. miR-106b-5p, miR-200c-3p, and miR-92a-3p exhibited significantly different expression profiles among the groups. In particular, miR-106b-5p and miR-200c-3p were expressed at higher levels in patients with ITP compared to the normal controls. Furthermore, these two miRNAs expressions were even higher in patients with chronic ITP.
Conclusion:
MiR-106b-5p and miR-200c-3p may represent valuable biomarkers of ITP, although further studies are needed to confirm and assess the value of these potential biomarkers at various stages of ITP.
Insights
MicroRNAs (miRNAs) are involved in immune thrombocytopenia (ITP). Elevated levels of miR-106b-5p and miR-200c-3p were observed in ITP patients, suggesting their potential as diagnostic biomarkers.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) play a role in primary immune thrombocytopenia (ITP).
- Further investigation into miRNA involvement in ITP is warranted.
Purpose of the Study:
- To evaluate the role and expression profiles of miRNAs in newly diagnosed and chronic immune thrombocytopenia (ITP).
- To identify potential miRNA biomarkers for ITP diagnosis and staging.
Main Methods:
- Microarray analysis of miRNA and mRNA expression in ITP patients (newly diagnosed and chronic) and healthy controls.
- Application of the Pipeline of Outlier MicroRNA Analysis framework to identify key miRNAs.
- Validation using quantitative PCR and receiver operator characteristic curves.
Main Results:
- 14 key miRNAs (12 over-expressed, 2 under-expressed) in newly diagnosed ITP and 7 over-expressed miRNAs in chronic ITP were identified compared to controls.
- miR-106b-5p, miR-200c-3p, and miR-92a-3p showed significantly different expression patterns across groups.
- miR-106b-5p and miR-200c-3p were significantly upregulated in ITP patients, with higher levels in the chronic ITP group.
Conclusions:
- miR-106b-5p and miR-200c-3p show potential as valuable biomarkers for immune thrombocytopenia (ITP).
- Further research is necessary to confirm their diagnostic value across different ITP stages.
Related Concept Videos
01:24Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
01:36Humoral Immune Responses
01:20Random and Systematic Errors
01:38What is the Immune System?
01:17Systematic Sampling Method
Systematic sampling is one of the simplest methods...
01:10Propagation of Uncertainty from Systematic Error